Across TCGA pan-cancer cohorts, RPS26P3 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of RPS26P3’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RPS26P3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS26P3 is over-expressed in tumor, although a few such as STAD show the opposite, repressed pattern.
KIRC, KIRP, and LIHC are the cancer types where RPS26P3 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS26P3 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.